Molecular mechanisms underlying the effect of pioglitazone therapy in Non-Alcoholic Steatohepatitis (NASH)

Background and Aim: A recent randomised double-blind placebocontrolled trial (RCT) demonstrated that Pioglitazone therapy was effective in reducing hepatocellular injury and fibrosis in subjects with NASH. We aimed to investigate the molecular mechanisms underlying the effects of Pioglitazone in...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdul Rahim, Roslina, Aithal, Guruprasad Padur, Macdonald, Ian A., Bennett, Andrew J.
Format: Article
Language:English
Published: Elsevier, Inc. 2009
Subjects:
Online Access:http://irep.iium.edu.my/52366/1/EASL%202009.pdf
http://irep.iium.edu.my/52366/
http://www.journal-of-hepatology.eu/article/S0168-8278(09)60694-2/abstract
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first